[{"AccountsPayableCurrent_0_Q2_USD":10816000.0,"MarketingAndAdvertisingExpense_1_Q2_USD":47578000.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5257000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":37579000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":948178000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":40243000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":21928000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":213474000.0,"OtherLiabilitiesCurrent_0_Q2_USD":4746000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-36000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":12300000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":0.0,"InterestIncomeExpenseNet_2_Q2_USD":-22454000.0,"InterestIncomeExpenseNet_1_Q2_USD":-13151000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1308843000.0,"SellingExpense_2_Q2_USD":36627000.0,"SellingExpense_1_Q2_USD":18687000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":33513000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":22655000.0,"InterestPaid_2_Q2_USD":5609000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-4674000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":12880000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":12880000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-59959000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12802000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":421829000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":241030000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":2290000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1879573000.0,"MarketingAndAdvertisingExpense_2_Q2_USD":80093000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":693806000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1818000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":3090000.0,"PaymentsToAcquireSoftware_2_Q2_USD":6449000.0,"PaymentsToAcquireOtherInvestments_2_Q2_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":13500000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-4674000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":12880000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":30440000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":27940000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5763000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"LitigationReserveCurrent_0_Q2_USD":1820000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":2200000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-847000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-3765000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1428000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":24813000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":795918000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":5291000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":1627000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":2932000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":22142000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q2_USD":285601000.0,"AccruedInsuranceCurrent_0_Q2_USD":2480000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":24070000.0,"OtherAssetsNoncurrent_0_Q2_USD":19884000.0,"Goodwill_0_Q2_USD":742314000.0,"NetIncomeLoss_1_Q2_USD":-25682000.0,"NetIncomeLoss_2_Q2_USD":-55285000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":29230000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-21590000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":788278000.0,"LiabilitiesCurrent_0_Q2_USD":123548000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2418828000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1595000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":24773000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1844000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-3110000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-2399000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-58395000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-28081000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":99503000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":54383000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.74,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.34,"CostsAndExpenses_2_Q2_USD":450019000.0,"CostsAndExpenses_1_Q2_USD":248209000.0,"CommonStockValue_0_Q2_USD":79000.0,"CommonStockSharesOutstanding_0_Q2_shares":79099433.0,"CommonStockSharesIssued_0_Q2_shares":79099433.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1308843000.0,"AssetsCurrent_0_Q2_USD":1403110000.0,"Assets_0_Q2_USD":2418828000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-21913000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":1790000.0,"AccountsReceivableNetCurrent_0_Q2_USD":76902000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1641000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":14433000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9606000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-562810000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":163162000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":90780000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":213474000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":325931000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1838000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-7751000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-7751000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":18976000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":17900000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":9000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":5113000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":18683000.0,"ShareBasedCompensation_2_Q2_USD":40243000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42286000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":2473000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23029000.0,"OperatingIncomeLoss_2_Q2_USD":-28190000.0,"OperatingIncomeLoss_1_Q2_USD":-7179000.0,"InterestPayableCurrent_0_Q2_USD":2046000.0,"IncomeTaxesPaidNet_2_Q2_USD":59000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":112457000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"DepreciationAndAmortization_2_Q2_USD":19603000.0,"DepreciationAndAmortization_1_Q2_USD":9893000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":74919194.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":76512870.0,"StockholdersEquity_0_Q2_USD":1294929000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":1000000000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":2473000.0,"Ticker":"TDOC","CIK":"1477449","name":"TELADOC HEALTH, INC.","OfficialName":"Teladoc Health Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10412953391.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Nursing Services","Market":"NYSE","SP500":"nan","filed":"20200730"}]